Middletown Life

Author: TransMedics Group, Inc.

TransMedics Reports Fourth Quarter and Full Year 2025 Financial Results

February 24, 2026
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

February 20, 2026
TransMedics to Present at Upcoming March Investor Conferences

February 17, 2026
TransMedics to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

February 13, 2026
TransMedics Receives Full and Unconditional FDA IDE Approval for Next-Generation OCS Heart ENHANCE Trial

February 12, 2026
TransMedics Announces New Global Headquarters and Expansion at Assembly Innovation Park in Somerville, Massachusetts

January 12, 2026
TransMedics to Participate in the 44th Annual J.P. Morgan Healthcare Conference

December 30, 2025
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

December 24, 2025
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

November 3, 2025